Loss of Beclin 1 expression, presumably related to allelic loss of the gene or microRNA regulatory activity as suggested in the literature, defines poor prognosis by promoting anti-apoptotic pathways, whereas overexpression of the protein, being linked with tumour hypoxia and acidity, also defines subgroups of tumours with an aggressive clinical behaviour. Here, BECN1 is linked to neoplasm.